About Compendia Bio
Compendia Bio is a company based in Ann Arbor (United States) founded in 2006 was acquired by Life Technologies in October 2012. Compendia Bio operates in a competitive market with competitors including Human Longevity, DNAnexus, Genomics, Seven Bridges Genomics and Depixus, among others.
- Headquarter Ann Arbor, United States
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$1.33 M (USD), Grant
Aug 01, 2010
-
Investors
HHS
& 1 more
-
Employee Count
Not available
-
Acquired by
Life Technologies
(Oct 08, 2012)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Compendia Bio
Investors in Compendia Bio
Compendia Bio has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Life Technologies.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Tools and technologies for biotech and biopharma research were supplied.
|
Locked | Locked | Locked |
Investor details for Compendia Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Compendia Bio
Investment portfolio details for Compendia Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Compendia Bio
Detailed financials for Compendia Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Compendia Bio Comparisons
Peer comparison for Compendia Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Compendia Bio
Compendia Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Human Longevity, DNAnexus, Genomics, Seven Bridges Genomics and Depixus, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomics data and cell therapy-based diagnostic and therapeutic solutions
|
|
| Locked | Locked | Locked |
Cloud-based genome informatics and data management are provided.
|
|
| Locked | Locked | Locked |
Genomic risk assessment and prevention platform is provided.
|
|
| Locked | Locked | Locked |
Cloud-based platform to analyze, store, and act on genomic data.
|
|
| Locked | Locked | Locked |
Single-molecule genetic and epigenetic sequencing solutions are provided.
|
|
| Locked | Locked | Locked |
Genomic data is analyzed and interpreted via web-based applications.
|
Detailed competitors of Compendia Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Compendia Bio
Complete news archive for Compendia Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Compendia Bio
Compendia Bio was founded in 2006 and raised its 1st funding round 1 year after it was founded.
Compendia Bio is headquartered in Ann Arbor, United States. It is registered at Ann Arbor, Michigan, United States.
Compendia Bioscience specializes in collecting, analyzing, and integrating cancer genomics data for drug development, diagnostics and personalized medicine. Data collection process includes direct correspondence with study authors to gather all available sample facts, often beyond those presented in the original publication. Its main products are Oncomine, aggregates and analyze the oncology data and provide practical, actionable views on the data and results. Oncopredictor, a biomarker discovery platform, performs comprehensive analyses to identify genomic biomarkers of in vitro drug response and importantly, predicts patient populations most likely to benefit from the drug, oncology companion diagnostics platform, Oncoscore, leverages the molecular diversity of cancer to provide deep molecular sub-typing of cancer patients. On October 8, 2012 the company was acquired by Life Technologies, which is a part of Thermo Fisher Scientific.
Compendia Bio's top competitors include DNAnexus, Human Longevity and Eagle Genomics.
Compendia Bio has 2 investors. Key investors include HHS, and Life Technologies.